EUVIMEDEUVIMED entdecken
Crossref

Molecular Prevalence and Liver Enzymes Profile in Occult Hepatitis B Infection among Blood Donors

Kauthar Mohammad, Shuaibu Abdullahi Hudu, Ahmed Subeh Alshrari, Usman Aliyu Dutsinma

Advancements in Life Sciences · 10.04.2026 · 13 (1) · 3587

DOI: 10.62940/als.v13i1.3587 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advancements in Life Sciences, online erschienen am 10.04.2026. Verfasst von Kauthar Mohammad und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Occult hepatitis B infection (OHBI), defined as positive seroreactivity for HBV DNA and negative seroreactivity for hepatitis B surface antigen (HBsAg), poses a challenge due to its hidden and asymptomatic nature. This study aimed to investigate the molecular rate of OHBI in blood donors and to assess the accompanying liver function profile.

Methods

Blood specimens from 200 HBsAg-negative blood donors were tested by a rapid chromatographic assay (Micro-point combo kit, USA) for HBV serological markers (HBsAg, HBsAb, HBeAg, HBeAb, and HBcAb) and detection of HBV DNA by nested PCR.

Results

Of the 200 HBsAg-negative donors, 160 (80%) were seronegative for any hepatitis B serologic marker. Conversely, 5 (2.5%) HBsAb+, 4 (2%) HBcAb+, 11 (5.5%) HBsAb+HBcAb+, 20 (10%) HBcAb+HBeAb+ were positive. Of significance, 4 (2%) donors had evidence of HBV DNA, corresponding to a 2% OHBI prevalence in this population. Moreover, OHBI-positive donors presented higher levels of liver enzymes indicative of potential liver injury. OHBI was detected in 2% of blood donors, showing the risk of HBV transmissibility by blood transfusion from those who are seemingly negative for HBsAg. In addition, the high liver enzymes in OHBI-positive donors may signify a link with the outcome of chronic HBV infection.

Conclusions

Our data suggest the need to develop a sensitive screening strategy to identify OHBI among blood donors in order to reduce HBV transmission. It also highlights the importance of monitoring liver function tests in OHBI-positive individuals to prevent possible liver-related complications sequelae.Keywords:Blood donors, Blood transfusion, Liver function, Occult hepatitis B infection

Zitieren

APA

Mohammad, K., Hudu, S. A., Alshrari, A. S., & Dutsinma, U. A. (2026). Molecular Prevalence and Liver Enzymes Profile in Occult Hepatitis B Infection among Blood Donors. Advancements in Life Sciences, 13(1), 3587. https://doi.org/10.62940/als.v13i1.3587

Vancouver

Mohammad K, Hudu SA, Alshrari AS, Dutsinma UA. Molecular Prevalence and Liver Enzymes Profile in Occult Hepatitis B Infection among Blood Donors. Advancements in Life Sciences. 2026;13(1):3587. doi:10.62940/als.v13i1.3587

BibTeX
@article{Mohammad2026,
  author = {Mohammad, Kauthar and Hudu, Shuaibu Abdullahi and Alshrari, Ahmed Subeh and Dutsinma, Usman Aliyu},
  title = {Molecular Prevalence and Liver Enzymes Profile in Occult Hepatitis B Infection among Blood Donors},
  journal = {Advancements in Life Sciences},
  year = {2026},
  volume = {13},
  number = {1},
  pages = {3587},
  doi = {10.62940/als.v13i1.3587}
}
Kostenlos starten →